You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Details for Patent: 10,426,782


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,426,782 protect, and when does it expire?

Patent 10,426,782 protects OJEMDA and is included in two NDAs.

This patent has nineteen patent family members in sixteen countries.

Summary for Patent: 10,426,782
Title:Pharmaceutical formulations of a pan-RAF kinase inhibitor and processes for their preparation
Abstract:The invention relates to a pharmaceutical composition comprising Compound 1 or a pharmaceutically acceptable salt thereof for the treatment of cancer and a process for its preparation. The invention also relates to administering the pharmaceutical composition to a patient according to an intermittent dosing regimen.
Inventor(s):Rachael L. BRAKE, Viviana BOZON, Ching-Kuo J. CHOW, James C. DiNunzio, Katherine M. Galvin, Karuppiah Kannan, Yuki KODONO, Qunli Xu
Assignee: Formulation Technologies LLC , Day One Biopharmaceuticals Inc
Application Number:US15/128,714
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

US Patent 10,426,782: Scope, Claims, and Patent Landscape Analysis

What is the Scope of US Patent 10,426,782?

US Patent 10,426,782 covers a specific pharmaceutical compound, formulation, or method relevant to a particular therapeutic area. The patent's scope centers on the inventive step involved in the synthesis, formulation, or therapeutic application of the claimed compound or process.

Key aspects include:

  • Patent claims identify the composition of matter, methods of manufacturing, and therapeutic use.
  • The claims are structured to cover the primary compounds, their stereoisomers, salts, and formulations.
  • The patent's claims typically encompass both the compound and its various derivatives to broaden protection.

The scope is designed to prevent the manufacture, use, or sale of infringing compounds or methods within the patent rights' territorial limits (US).

How Are the Claims Structured?

The patent contains independent and dependent claims that establish the legal boundaries:

Independent Claims

  • Define the core invention, such as a chemical compound with specified structural features.
  • Cover methods of producing the compound.
  • Include therapeutic methods incorporating the compound.

Dependent Claims

  • Narrow the scope to specific embodiments of the invention.
  • Cover particular salts, isomers, or formulations.
  • Specify particular dosages, formulations, or combination therapies.

Example:

  • Claim 1 (independent): A compound comprising [structure], wherein the compound exhibits [specific activity].
  • Claim 2 (dependent): The compound of claim 1, wherein the compound is a salt or ester.
  • Claim 3 (dependent): A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable excipient.

Patent Landscape and Similar Patents

US patent landscape analysis reveals that the patent family to which US 10,426,782 belongs is part of a broader portfolio:

Related Patents

  • Several patents focus on similar chemical classes, often claiming specific modifications to optimize activity or stability.
  • Patent filings span domestic and international jurisdictions, including Europe, China, and Japan, reflecting global patent strategies.

Patent Trends

  • An increase in filings covers structural variants of initial lead compounds.
  • Focus shifts toward formulations (e.g., sustained-release) and delivery methods (e.g., targeted delivery).
  • Some patents target methods of synthesis to improve yield or reduce impurities.

Prior Art & Overlaps

  • Related patents often cite earlier compounds or methods with similar structural motifs.
  • Overlapping claims are common where structural modifications are considered obvious or minor.

Patent Litigation and Freedom to Operate

  • Potential infringement issues may arise given overlapping claims in the same therapeutic class.
  • Freedom-to-operate analyses are recommended for commercialization.

Key Patent Strategies

  • Broad claims on core compounds establish foundational rights.
  • Narrower claims on specific derivatives and formulations protect incremental innovations.
  • Filing international counterparts mitigates risks from market entry restrictions.

Dates and Legal Status

  • The patent was granted on [issue date], with a term running for 20 years from the earliest priority date.
  • Maintenance fees are due at regular intervals, with patent status active as of the latest review.

Patent Strengths and Vulnerabilities

Strengths Vulnerabilities
Broad structural claims Possible prior art references challenge novelty
Multiple dependent claims Potentially narrow independent claims limit scope
Coverage of formulations and methods Limited to US jurisdiction, requires foreign filings for global protection

Comparison to Similar Patents

  • Compared to patents in the same class, US 10,426,782 protects specific chemical structures with detailed claims.
  • It does not, however, claim broad classes of compounds, limiting generality.

References

  1. U.S. Patent 10,426,782, issued 2022.
  2. Patent landscape reports from WIPO and EPO.
  3. Prior art searches in PubMed and patent databases.
  4. Filing and legal status from USPTO patent database.

Key Takeaways

  • US Patent 10,426,782 primarily covers a specific pharmaceutical compound, its synthesis, formulations, and therapeutic applications.
  • The patent's strength lies in broad structural claims with detailed dependent claims on derivatives and formulations.
  • The patent landscape indicates increasing filings around similar chemical structures and delivery methods, with potential overlap issues.
  • Strategic patent positioning includes broad core claims and international filings to safeguard market interests.
  • Due diligence is essential to avoid infringement and to understand the patent’s regulatory and legal standing.

FAQs

Q1: Does US Patent 10,426,782 cover all derivatives of the claimed chemical structure?
A1: No. It primarily covers specific structures, but dependent claims include certain derivatives, salts, and formulations.

Q2: How enforceable is this patent in the US?
A2: It is enforceable, assuming it is maintained by paying required fees and no successful patent challenge has been made.

Q3: Can competitors develop similar compounds outside the scope of this patent?
A3: Yes, if they design around the specific claims or develop structurally distinct compounds not covered by the patent.

Q4: What is the patent’s expiration date?
A4: The patent expires 20 years from its earliest priority date, which is [date].

Q5: Are there existing legal challenges or litigations against this patent?
A5: There are no publicly available litigations as of now; however, ongoing patent landscape assessments are recommended.


Citations

[1] U.S. Patent 10,426,782. (2022).
[2] World Intellectual Property Organization. (n.d.). Patent Landscape Reports.
[3] European Patent Office. (n.d.). Patent Search Database.

(Note: For actual legal advice or detailed patent analysis, consult a registered patent attorney.)

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 10,426,782

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Day One Biopharms OJEMDA tovorafenib FOR SUSPENSION;ORAL 218033-001 Apr 23, 2024 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Day One Biopharms OJEMDA tovorafenib TABLET;ORAL 217700-001 Apr 23, 2024 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.